Quantifying atherogenic lipoproteins for lipid-lowering strategies: consensus-based recommendations from EAS and EFLM

European Atherosclerosis Soc, European Federation Clinical Chem, Michel R. Langlois, Borge G. Nordestgaard, Anne Langsted, Päivi Laitinen

Research output: Contribution to journalArticleScientificpeer-review

Original languageEnglish
JournalClinical Chemistry and Laboratory Medicine
Volume58
Issue number4
Pages (from-to)496-517
Number of pages22
ISSN1434-6621
DOIs
Publication statusPublished - Apr 2020
MoE publication typeA1 Journal article-refereed

Fields of Science

  • apolipoprotein B
  • atherosclerotic cardiovascular disease
  • LDL cholesterol
  • lipoprotein(a)
  • non-HDL cholesterol
  • remnant cholesterol
  • CORONARY-HEART-DISEASE
  • NON-HDL CHOLESTEROL
  • TRIGLYCERIDE-RICH LIPOPROTEINS
  • CARDIOVASCULAR RISK REDUCTION
  • NUCLEAR-MAGNETIC-RESONANCE
  • APOLIPOPROTEIN-B LEVELS
  • DIVISION WORKING GROUP
  • LDL-CHOLESTEROL
  • FAMILIAL HYPERCHOLESTEROLEMIA
  • CLINICAL-CHEMISTRY
  • 3111 Biomedicine

Cite this